Health
CREB1: A Potential Target for Treating Pancreatic Cancer – Technology Networks
Preclinical research using cell lines, genetic mouse models and human pancreatic tumor tissue samples has identified the transcription factor CREB1 as a potential…
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor CREB1 (for cyclic AMP-responsive element binding protein 1) as a potential therapeutic target for the treatment of pancreatic cancer, according to results presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15. This study is being simultaneously published in Cancer Discovery, a journal of the American Association for Cancer Research.
Pancreatic…
-
Noosa News16 hours agoJazz sellout at The J
-
General15 hours agoAnne-Marie Te Whiu on new book of poetry, Mettle, and why she dedicated it to her younger self
-
General12 hours agoRecord forecast for Australia’s world-class agriculture
-
Noosa News12 hours agoMigration blunders lead to strike-off – Proctor